PureTech Health plc (PRTC)
NASDAQ: PRTC · Real-Time Price · USD
18.14
+0.79 (4.55%)
Apr 28, 2026, 4:00 PM EDT - Market closed
PureTech Health Employees
PureTech Health had 56 employees as of December 31, 2024. The number of employees decreased by 34 or -37.78% compared to the previous year.
Employees
56
Change (1Y)
-34
Growth (1Y)
-37.78%
Revenue / Employee
$114,125
Profits / Employee
$904,964
Market Cap
427.41M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Vanda Pharmaceuticals | 533 |
| Rocket Pharmaceuticals | 202 |
| Neurogene | 131 |
| Invivyd | 122 |
| Enanta Pharmaceuticals | 120 |
| Niagen Bioscience | 117 |
| Neumora Therapeutics | 96 |
| Century Therapeutics | 78 |
PRTC News
- 1 day ago - PureTech Founded Entity Seaport Therapeutics Adds Intra-Cellular Therapies Founder and CEO, Dr. Sharon Mates, to its Board of Directors - Business Wire
- 6 days ago - Positive Phase 1b Results for PureTech Health (PRTC) - GuruFocus
- 6 days ago - PureTech Reports Positive Topline Data from Phase 1b Trial of LYT-200 in Relapsed/Refractory (R/R) High-Risk (HR) Myelodysplastic Syndrome (MDS) and R/R Acute Myeloid Leukemia (AML) - Business Wire
- 15 days ago - PureTech Health: Notice of Results - Business Wire
- 26 days ago - PureTech Health (PRTC) Advances Deupirfenidone for Pulmonary Fibrosis Treatment - GuruFocus
- 26 days ago - PureTech Announces Publication of Phase 2b ELEVATE IPF Trial Results in The American Journal of Respiratory and Critical Care Medicine - Business Wire
- 4 weeks ago - PureTech Founded Entity Seaport Therapeutics Announces Publication in Science Translational Medicine Featuring GlyphAllo™ (SPT-300) as the First Triglyceride-Mimetic Prodrug to Achieve Therapeutically Relevant Drug Levels in Humans - Business Wire
- 6 weeks ago - PureTech Health Transcript: Leerink Global Healthcare Conference 2026 - Transcripts